Skip to main content

Fight against pandemics

Women and children’s health

Funding and quality of aid

Research and Development

Opinions

EU Pharma Strategy
Blog series

Transparency is key to unlocking better policies

By Ellen T'Hoen, lawyer and director of Medicine Law & Policy

Social network

To stay in touch with Global Health Advocates,
follow us on Twitter

🚨💉Big Pharma : une influence « démesurée » sur l'UE, selon un rapport de @STOPAIDS, @GHABrussels et @GHAFrance
https://www.euractiv.fr/section/sante-modes-de-vie/news/un-nouveau-rapport-denonce-linfluence-demesuree-des-big-pharma-sur-lue/

Riches échanges entre @MSuzman, DG de @gatesfoundation, et des députés 🇫🇷ce matin.

Une discussion croisée sur le rôle et priorités de la France et de la Fondation pour lutter contre les inégalités mondiales et tendre vers un accès universel à la santé.

#DirectAN
Audition de @CZacharopoulou en @AN_AfEtr, l’occasion de faire le point sur la point sur la politique de développement de la France 🇫🇷

🧵⤵️

Trust in public health decision-making requires transparency, not secrecy.

In the case of #Covid19 contracts, protecting commercial interests came at the expense of transparency, damaging public health & prolonging the pandemic #AccessDenied

Read more: https://bit.ly/3wcgz1h

In the beginning, the #EU advocated for global solidarity in the #COVID19 response & recognised vaccines as global public goods... yet ended up going off track, resulting in #AccessDenied for low-and-middle income countries.

Read more: https://bit.ly/3wcgz1h

NEW: @STOPAIDS and @GHABrussels‘ report series demonstrates how a lack of transparency in the pharmaceutical industry and the EU has harmed public health outcomes during the #COVID19. #AccessDenied

Read more: https://bit.ly/3wcgz1h